Log in

6550 Polaris Group TWSE · Taiwan

Polaris Group (6550) news

Polaris Group is a public biotech or pharmaceutical company listed on TWSE under the ticker 6550, recorded under Taiwan. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Polaris Group news

We have not published a story on Polaris Group yet. When there is news, it will appear here.

Questions about Polaris Group

What is the ticker symbol of Polaris Group?

Polaris Group trades under the ticker 6550 on TWSE.

Where is Polaris Group listed?

Polaris Group is listed on TWSE.

Which country or territory is Polaris Group listed under?

Our directory records Polaris Group under Taiwan.

What does Polaris Group do?

Our directory classifies Polaris Group as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Polaris Group?

The ISIN recorded for Polaris Group is KYG7171A1085.

Does aibio.space cover Polaris Group?

aibio.space lists Polaris Group among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Polaris Group?

Companies in our directory listed in the same country and business area as Polaris Group: Ever Supreme Bio Technology Co., Syngen Biotech Co., Obigen Pharma, TaiwanJ Pharmaceuticals Co., Shine-On Biomedical Co., HCmed Innovations Co..

Investor discussion: Polaris Group

Members talk about Polaris Group (6550). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TWSE:6550 on TradingView.

Listing details

Polaris Group is a public biotech or pharmaceutical company listed on TWSE under the ticker 6550, recorded under Taiwan. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Polaris Group
Ticker
6550
Listing
TWSE
Country or territory
Taiwan
Business scope
Biotechnology
ISIN
KYG7171A1085
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.